Published on:December 2018
    Journal of Pharmacy Practice and Community Medicine, 2018; 4(4):193-196
    Review Article | doi:10.5530/jppcm.2018.4.46


    Utilization of Statins in Reducing Comorbidities of Diabetes Mellitus: A Systematic Review


    Authors and affiliation (s):

    Mudasir Maqbool*, Imran Gani

    Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal Srinagar-190006, Jammu and Kashmir, INDIA

    Abstract:

    Diabetes mellitus is a group of metabolic diseases characterized by hyperglycaemia resulting from defects in insulin secretion, action or both. Medical care for the patients with diabetes, especially medication regimens, has become more complex over time, producing a barrier to achieving evidence-based goals of treatment. Diabetes Mellitus has been found to be a major cause of heart disease, stroke and death. Patients with diabetes have heart disease, death rates and risk for stroke about 2 to 4 times higher than adults without diabetes An overwhelming amount of data that confirm the morbidity and mortality benefit of statin therapy in diabetes mellitus have been reported, both in primary and secondary prevention settings. National and international clinical guidelines in the prevention of cardiovascular risk in diabetics advocate the utilization of statin therapy in appropriate patients. In this review, we will systematically review about utilization of Statins in reducing Comorbidities of Diabetes Mellitus.

    Key words: Diabetes Mellitus, Statins, Cardiovascular risk, Comorbidities.

    Download Article >>

     




     

    Cite this article as

    Maqbool M, Gani I. Utilization of Statins in Reducing Comorbidities of Diabetes Mellitus: A Systematic Review. Journal of Pharmacy Practice and Community Medicine. 2018;4(4):193-6. Abstract